Gene Therapy for ACM Due to a PKP2 Pathogenic Variant
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06109181 |
|
Recruitment Status :
Recruiting
First Posted : October 31, 2023
Last Update Posted : April 3, 2024
|
Sponsor:
Lexeo Therapeutics
Information provided by (Responsible Party):
Lexeo Therapeutics
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | February 2026 |
| Estimated Study Completion Date : | February 2027 |